BIO-TECHNE Corp
TECH· Nasdaq
Filed Feb 9, 2011 · 10-Q · 40 days after period end · 0000950123-11-010727
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $67.71M | $65.52M |
| Net Income | $26.53M | $24.72M |
| EPS Diluted | $0.71 | $0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
ended Dec 31, 2010 · filed Feb 9, 2011 · 40 d after period end